Bottom line: Sen. Harris’s plan is just another entry way to force government-run healthcare on everyone.
Is the Prescription Drug Pricing Reduction Act Another Obamacare?
For weeks, there was little information on what would be in the legislation since it was being discussed and written behind closed doors.
Colorado and California Take Action to Lower Obamacare Premiums
A July 23, 2019 Inside Health Policy healthcare column discusses predictions made by Colorado and California state officials on the cost of their insurance premiums in 2020 due to actions they took to make the Patient Protection and Affordable Care Act (ACA), or Obamacare, more affordable. Colorado applied for a 1332 state innovation waiver that […]
Socialist Drug Price Controls Should be Rejected
It has been often said that in Washington, D.C. bad news comes out on a Friday afternoon and today, July 19, 2019, is no exception
V.P. Biden’s Plan is Really a Side Door to Medicare for All
Today, former Vice President and 2020 Democratic presidential candidate Joe Biden offered his healthcare plan, the “Affordable Care Act 2.0.” It would keep and build on Obamacare and provide a public option or mechanism for people to buy into a government-run plan. Biden says he would provide “free premiums” to low-income people that live in […]
Drug Price Controls Push Innovation Out of the Picture
As the debate over Speaker Nancy Pelosi’s (D-Calif.) effort to increase government control over drug pricing heats up, a familiar proposal has also drawn scrutiny. Rep. Lloyd Doggett’s (D-Texas) bill, H.R. 1046, the Medicare Negotiation and Competitive Licensing Act, was introduced on February 7, 2019 and has 126 cosponsors in the House. This legislation would […]
CAGW Weighs In on Important Announcements on Drug Pricing
Two important news items regarding pharmaceutical prices have been announced within the past week: a judge’s decision on a Trump administration rule that would have forced drug companies to provide the wholesale acquisition cost (WAC) of a drug in their television ads and a forthcoming executive order concerning drug prices.
Senate Finance Committee Drug Pricing Changes – Market Driven or More Destructive Price Controls?
Senate should be reminded when considering drug plans for Medicare and Medicaid that competition always leads to lower drug costs.
The American Medical Association’s Shaky Stance on Socialized Medicine
As the American Medical Association’s (AMA) shrinking membership tilts further and further to the left, real questions need to be asked about the organization’s influence over the Medicare for All debate. After the AMA resisted Medicare in 1966, roughly 70 percent of doctors were registered members of the group. During the Clinton era, the AMA […]
Hang Onto Your Wallets … And Your Freedom
Listening to the Democratic presidential debates these past two days has been alarming. Pandering to specific groups, the candidates are prepared to have the federal government cover the costs for a myriad of programs. The New York Times wrote, “The Democrats’ two nights of debates showed that liberalism is on the march in the party. […]